ابتورافي 200مكجم 140 اقراص

ما هو دواء ابتورافي 200مكجم 140 اقراص

جرعة دواءابتورافي 200مكجم 140 اقراص

يستعمل دواء ابتورافي 200مكجم 140 اقراصuptravi 200 mcg 140 f.c.tabs. prostacyclin receptor agonist prostacyclin receptor agonist

indication -uptravi� (selexipag) is indicated for the treatment of pulmonary arterial hypertension (pah who group i) to delay disease progression and reduce the risk of hospitalization for pah. - -effectiveness was established in a long-term study in pah patients with who functional class ii-iii symptoms. - -patients had idiopathic and heritable pah (58%) pah associated with connective tissue disease (29%) and pah associated with congenital heart disease with repaired shunts (10%).

تركيبة دواءابتورافي 200مكجم 140 اقراصuptravi 200 mcg 140 f.c.tabs.

يتركب هذا الدواء من :selexipag